Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market

May 17, 2023

https://www.globenewswire.com/news-release/2023/05/17/2670795/0/en/Opthea-to-Participate-in-EF-Hutton-Hosted-Discussion-on-OPT-302-and-the-Wet-AMD-Market.html

MELBOURNE, Australia, May 17, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Elemer Piros, Senior Biotechnlogy Analyst at EF Hutton will host a webinar with Dr. Megan Baldwin, CEO and Managing Director and Timothy E. Morris, CFO of Opthea Limited on Thursday, May 18th at 5:00 pm EDT (Friday, May 19th at 7:00 am AEST).

Read more at globenewswire.com

Related news for (OPT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.